Jennifer E Axilbund,Elizabeth A Wiley
Jennifer E Axilbund
It is estimated that 5% to 10% of pancreatic cancer is familial. Although there is evidence of a major pancreatic cancer susceptibility gene, the majority of families with multiple cases of pancreatic cancer do not have an identifiable caus...
Gayun Chan-Smutko
Gayun Chan-Smutko
The roles of renal cell carcinoma (RCC) and urothelial cancers of the upper urinary tract are often overlooked as indicators for genetic risk assessment. The key features of 5 hereditary cancer susceptibility conditions involving an increas...
Molly S Daniels
Molly S Daniels
This review article discusses hereditary cancer predisposition syndromes with uterine manifestations. Lynch syndrome accounts for 2% to 3% of endometrial cancers. The identification of endometrial cancer patients at risk for Lynch syndrome ...
Leigha Senter
Leigha Senter
Lynch syndrome, which is associated with mutations in 1 of 4 mismatch repair genes (MLH1, MSH2, MSH6, and PMS2), is a well-described hereditary cancer predisposition syndrome associated with a substantial risk of colon, rectum, and endometr...
Kory W Jasperson
Kory W Jasperson
Hereditary colonic polyposis conditions are all characterized by high rates of cancer, but they have diverse phenotypes, genetic heterogeneity, and assorted inheritance patterns. The most well known of these conditions include familial aden...
Scott M Weissman,Shelly M Weiss,Anna C Newlin
Scott M Weissman
Approximately 1 in every 4 to 5 women with a diagnosis of ovarian cancer has a hereditary gene mutation that is responsible for the development of her cancer. Identifying women at increased risk of developing ovarian cancer due to a heredit...
Kristen Mahoney Shannon,Anu Chittenden
Kristen Mahoney Shannon
Women in the United States have a 12% lifetime risk of developing breast cancer. Although only about 5% to 10% of all cases of breast cancer are attributable to a highly penetrant cancer predisposition gene, individuals who carry a mutation...
Adverse events in cancer genetic testing: medical, ethical, legal, and financial implications [0.03%]
肿瘤基因检测的不良反应:医疗、伦理、法律和金融影响
Karina L Brierley,Erica Blouch,Whitney Cogswell et al.
Karina L Brierley et al.
Cancer genetic counseling and testing are now integral services in progressive cancer care. There has been much debate over whether these services should be delivered by providers with specialized training in genetics or by all clinicians. ...
Direct-to-consumer personal genome testing and cancer risk prediction [0.03%]
直接面向消费者的个人基因组检测与癌症风险预测
Cecelia A Bellcross,Patricia Z Page,Dana Meaney-Delman
Cecelia A Bellcross
The last several years has witnessed an explosion in genomics, with the advent of genome-wide association studies revealing hundreds of DNA variants significantly associated with most common diseases, including cancer. On the heels of these...
Whole-genome and whole-exome sequencing in hereditary cancer: impact on genetic testing and counseling [0.03%]
遗传性癌症的全基因组和全外显子组测序对基因检测和咨询的影响
Julianne M ODaniel,Kristy Lee
Julianne M ODaniel
The incorporation of whole-genome and whole-exome sequencing into clinical practice will undoubtedly change the way genetic counselors and other clinicians approach genetic testing. Enabling the analysis of essentially all human genes in on...